STAAR Surgical Revenue 2010-2024 | STAA

STAAR Surgical revenue from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
STAAR Surgical Annual Revenue
(Millions of US $)
2023 $322
2022 $284
2021 $230
2020 $163
2019 $150
2018 $124
2017 $91
2016 $82
2015 $77
2014 $75
2013 $72
2012 $64
2011 $63
2010 $55
2009 $51
STAAR Surgical Quarterly Revenue
(Millions of US $)
2024-06-30 $99
2024-03-31 $77
2023-12-31 $76
2023-09-30 $80
2023-06-30 $92
2023-03-31 $74
2022-12-31 $64
2022-09-30 $76
2022-06-30 $81
2022-03-31 $63
2021-12-31 $59
2021-09-30 $58
2021-06-30 $62
2021-03-31 $51
2020-12-31 $46
2020-09-30 $47
2020-06-30 $35
2020-03-31 $35
2019-12-31 $39
2019-09-30 $39
2019-06-30 $40
2019-03-31 $33
2018-12-31 $31
2018-09-30 $32
2018-06-30 $34
2018-03-31 $27
2017-12-31 $25
2017-09-30 $23
2017-06-30 $22
2017-03-31 $20
2016-12-31 $22
2016-09-30 $20
2016-06-30 $21
2016-03-31 $19
2015-12-31 $21
2015-09-30 $19
2015-06-30 $19
2015-03-31 $19
2014-12-31 $17
2014-09-30 $18
2014-06-30 $20
2014-03-31 $20
2013-12-31 $19
2013-09-30 $17
2013-06-30 $18
2013-03-31 $18
2012-12-31 $16
2012-09-30 $16
2012-06-30 $16
2012-03-31 $16
2011-12-31 $16
2011-09-30 $15
2011-06-30 $16
2011-03-31 $15
2010-12-31 $14
2010-09-30 $13
2010-06-30 $14
2010-03-31 $14
2009-12-31 $13
2009-09-30 $12
2009-06-30 $13
2009-03-31 $12
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $1.725B $0.322B
Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $68.856B 18.65
McKesson (MCK) United States $62.948B 17.32
Cardinal Health (CAH) United States $27.095B 14.99
West Pharmaceutical Services (WST) United States $21.509B 41.94
Cooper (COO) United States $21.095B 30.03
Labcorp (LH) United States $18.136B 15.10
Align Technology (ALGN) United States $18.028B 34.83
Henry Schein (HSIC) United States $8.941B 16.37
Merit Medical Systems (MMSI) United States $5.567B 29.42
DENTSPLY SIRONA (XRAY) United States $5.112B 13.71
CONMED (CNMD) United States $2.053B 17.85
Patterson (PDCO) United States $1.816B 9.58
Lifevantage (LFVN) United States $0.142B 19.66
Pro-Dex (PDEX) United States $0.104B 50.06